19 August 2021 | News
To provide a differentiated country-based assessment of the negative consequences of COVID-19 on the provision of anti-tuberculosis care
image credit- shutterstock
A consortium of doctors and researchers from India, Brazil, Russia, and South Africa have partnered to conduct a study on the epidemiological impact and intersection of the COVID-19 and tuberculosis (TB) pandemics in these countries.
Under this joint research, the teams from these countries will explore the negative impact of the COVID-19 pandemic on the epidemiological characteristics of TB infection and search for mechanisms responsible for the interaction of these two processes.
They will also search for strategies to mitigate the negative consequences of the pandemic and develop individual recommendations for each participating country, which can help overcome the impact of epidemics of respiratory viral diseases on the epidemic of tuberculosis.
The teams will assess the impact of COVID-19 on trends in the structure of the M. tuberculosis population, primarily through the interaction between scientists from Russia and India.
The teams from Brazil and South Africa will evaluate the impact of tuberculosis on the clinical course and treatment outcomes for COVID-19 at the individual level. The impact of the COVID-19 pandemic and associated restrictive measures on morbidity and tuberculosis-related mortality will be assessed using mathematical modeling.